Fig. 1: Schematic diagram of the study.
From: Anti-obesity effect of irreversible MAO-B inhibitors in patients with Parkinson’s disease
This diagram summarizes previous research in the sections “Background” and “Mice model”. Our study, which verifies the potential anti-obesity effects on humans, is presented in the “Clinical verification” section. Key points for future research are highlighted in the lower section.
